Loading chat...
OH SR488
Resolution
Status
Prefiled
N/A
Primary Sponsor
Capri Cafaro
Click for details
AI Summary
- American Cancer Society estimates approximately 1,685,210 new cancer cases will be diagnosed in 2016 and approximately 595,690 Americans will die from cancer that year
- National Institutes of Health estimates direct medical costs of cancer were nearly $125 billion in 2013 and are expected to reach at least $158 billion by 2020
- Global spending on cancer drugs increased from $37 billion a decade ago to $91 billion in 2013
- Insurance plans often place cancer medications in payment tiers requiring patients to pay 20% to 40% of medication costs out-of-pocket
- Approximately one in eight people with advanced cancer decline recommended care due to cost
- Ohio Senate urges Congress, the Food and Drug Administration, and the National Institutes of Health to address cancer drug costs and availability
- Senate directs the Clerk to transmit copies of this resolution to the U.S. House, U.S. Senate, FDA Commissioner, and NIH Director
Legislative Description
To urge the Congress of the United States, the United States Food and Drug Administration, and the National Institutes of Health to address the cost and availability of cancer drugs.
Last Action
Refer to Committee: Health and Human Services
5/18/2016
Committee Referrals
Health and Human Services5/18/2016
Full Bill Text
No bill text available